Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 12, 2025 16:05 ET | Source: Akoya Biosciences, Inc.

Akoya Biosciences Reports First Quarter 2025 Financial Results

Akoya Biosciences Reports First Quarter 2025 Financial Results
April 24, 2025 08:00 ET | Source: Akoya Biosciences, Inc.

Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025

Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025
April 24, 2025 08:00 ET | Source: Akoya Biosciences, Inc.

Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas

Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas
April 23, 2025 08:00 ET | Source: Akoya Biosciences, Inc.

Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore

AKOYA BIOSCIENCES AND SINGAPORE TRANSLATIONAL CANCER CONSORTIUM (STCC) PARTNER ON SUPER STUDY DESIGNED TO ADVANCE CANCER IMMUNOPHENOTYPING
April 02, 2025 08:00 ET | Source: Akoya Biosciences, Inc.

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities

Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler®-Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study
March 17, 2025 16:00 ET | Source: Akoya Biosciences, Inc.

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results
February 05, 2025 08:00 ET | Source: Akoya Biosciences, Inc.

Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels

Rapid menu expansion with new high-plex human and mouse neurobiology panels joining the recently launched Human IO60 and Mouse FFPE IO Panels The new offerings solidify leadership in spatial biology...
December 10, 2024 08:15 ET | Source: Akoya Biosciences, Inc.

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

MARLBOROUGH, Mass. and FRANKFURT, Germany, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company, and NeraCare, a leading developer of laboratory...
December 09, 2024 08:00 ET | Source: Akoya Biosciences, Inc.

Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone

MARLBOROUGH, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, announced that Nature Methods, one of the world’s leading...
November 14, 2024 16:00 ET | Source: Akoya Biosciences, Inc.

Akoya Biosciences Reports Third Quarter 2024 Financial Results

MARLBOROUGH, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the third quarter...

Next Page keyboard_arrow_right